UK Health Care At The Crossroads As Medtechs Watch For Bill, Brexit And NHS Change
Executive Summary
The UK health care system is keen to reshape in light of the lessons learned from COVID-19, but it comes at a time when Brexit trade issues and device regulatory system changes are already muddying the waters.
You may also be interested in...
Medtechs’ View Of UK Brexit Deal: More Certainty, But Still No Detail
COVID-19 is of no lesser importance to the UK medtech industry, but attention is now refocusing on Brexit, future regulation and trade deals.
UK MHRA In The Spotlight As Cumberlege Review Puts Medtech Safety At The Top Of Health Agenda
The findings of the Cumberlege Review into how safety issues for three medical product groups were handled will shape debate on the UK’s new devices legislation, now going through parliament. The MHRA’s devices regulatory activity also comes in for scrutiny.
Clinical Registries Database Mooted As UK Devices Bill Moves To Upper House
The UK’s post-EU standalone legislation for medical devices has continued its parliamentary journey, reaching the upper house this week. Debate on a clinical registries policy paper has begun.